Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M9,272Revenue (TTM) $M418Net Margin (%)-33.5Altman Z-Score27.2
Enterprise Value $M9,272EPS (TTM) $-1.0Operating Margin %-34.1Piotroski F-Score5
P/E(ttm)--Beneish M-Score1.2Pre-tax Margin (%)-33.5Higher ROA y-yY
Price/Book14.610-y EBITDA Growth Rate %-2.6Quick Ratio--Cash flow > EarningsY
Price/Sales22.15-y EBITDA Growth Rate %3.1Current Ratio--Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-16.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-21.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M142ROIC % (ttm)-81.6Gross Margin Increase y-yY

Gurus Latest Trades with SGEN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

SGEN is held by these investors:

SGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SIEGALL CLAY BPresident and CEO 2017-02-06Sell14,465$61.546.43view
SIEGALL CLAY BPresident and CEO 2017-01-06Sell14,465$57.8913.15view
Cline Darren SEVP, Commercial 2016-12-13Sell10,000$63.383.34view
DOBMEIER ERICCOO 2016-12-08Sell12,500$65.92-0.64view
HIMES VAUGHN BChief Technical Officer 2016-12-07Sell30,000$65.320.28view
SIEGALL CLAY BPresident and CEO 2016-12-06Sell14,465$66.17-1.01view
DRACHMAN JONATHAN GCMO & EVP, R & D 2016-11-09Sell7,751$66.75-1.87view
BAKER FELIXDirector, 10% Owner 2016-11-08Buy382,500$59.3610.34view
SIEGALL CLAY BPresident and CEO 2016-11-07Sell14,465$58.4312.1view
LIPPMAN MARC EDirector 2016-11-07Sell1,000$57.7513.42view

Quarterly/Annual Reports about SGEN:

News about SGEN:

Articles On GuruFocus.com
Insiders Buy Herbalife, Sell MasterCard Nov 05 2016 
Insiders Roundup: Theravance Biopharma, Western Gas, Upland Software Mar 18 2016 
Top Insider Trades of the Past Week Feb 19 2016 
Insiders Are Buying Barnes & Noble Sep 18 2015 
Vanguard Health Care Fund Buys Two New Stakes in Second Quarter Aug 06 2015 
Insiders keep on buying Macerich Co and Seattle Genetics May 22 2015 
Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA May 12 2015 
Seattle Genetics: Can Record Growth From Its Licenses Oct 28 2014 
Seattle Genetics: Can Record Sustained Growth From Royalty Aug 31 2014 
Will ImmunoGen’s Q4 Earnings Disappoint Again? Jul 30 2014 

More From Other Websites
Immunomedics Presents Updated Results With Sacituzumab Govitecan (IMMU-132) in Heavily-Pretreated... Feb 17 2017
VenBio Tries to Block Immunomedics Cancer Deal Feb 17 2017
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Seattle... Feb 17 2017
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Seattle Genetics Inc. of Commencement... Feb 17 2017
SEATTLE GENETICS INC /WA Files SEC form 8-K, Entry into a Material Definitive Agreement, Other... Feb 16 2017
SGEN INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Seattle... Feb 15 2017
SGEN NOTICE: Rosen Law Firm Reminds Seattle Genetics Inc. Investors of Important Deadline in Class... Feb 15 2017
IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against... Feb 15 2017
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Feb 15 2017
Biotech Stock Roundup: Regeneron's Praluent to Remain on Market for Now, GILD Presents HIV Data Feb 15 2017
Seattle Genetics signs $2B licensing deal with Immunomedics for cancer drug Feb 14 2017
SGEN SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Seattle... Feb 14 2017
DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And... Feb 14 2017
Activist Investor to Block Partnership of Immunomedics and Seattle Genetics Feb 14 2017
Seattle Genetics, Inc. :SGEN-US: Earnings Analysis: 2016 By the Numbers : February 14, 2017 Feb 14 2017
Activist Investor Seeks Legal Block of Immunomedics Cancer Drug Partnership With Seattle Genetics Feb 14 2017
IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Seattle... Feb 13 2017
SGEN SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action... Feb 13 2017
Here’s Our Take On The Immunomedics, Inc. (IMMU) Deal Feb 13 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)